Skip Nav Destination
Close Modal
Update search
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Journal
Article Type
Issue Section
Date
Availability
1-4 of 4
Keywords: Enfortumab vedotin
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Journal Articles
Subject Area:
Oncology
Michael Glover, Isabel Beshar, Austin McHenry, Cornelia Ding, Oliver Dorigo, Emily Chan, Sumit A. Shah
Journal:
Case Reports in Oncology
Case Rep Oncol (2025) 18 (1): 473–479.
Published Online: 10 March 2025
... vaginal cancer who demonstrated clinical, radiological, and molecular response to combination treatment of antibody-drug conjugate enfortumab vedotin (EV) with pembrolizumab. Conclusion: This is the first reported response to this combination therapy in vaginal cancer in the literature. The patient had...
Journal Articles
Subject Area:
Oncology
Ayatsugu Otsuka, Norifumi Sawada, Ryosuke Suda, Fumiakira Yano, Takuya Osada, Yuko Otake, Hiroshi Shimura, Takanori Mochizuki, Daiki Harada, Junko Goto, Tomomi Watanabe, Tadatsugu Hosokawa, Satoru Kira, Kyoichiro Tsuchiya, Takeshi Moriguchi, Takahiko Mitsui
Journal:
Case Reports in Oncology
Case Rep Oncol (2024) 17 (1): 891–899.
Published Online: 12 August 2024
...Ayatsugu Otsuka; Norifumi Sawada; Ryosuke Suda; Fumiakira Yano; Takuya Osada; Yuko Otake; Hiroshi Shimura; Takanori Mochizuki; Daiki Harada; Junko Goto; Tomomi Watanabe; Tadatsugu Hosokawa; Satoru Kira; Kyoichiro Tsuchiya; Takeshi Moriguchi; Takahiko Mitsui Introduction: Enfortumab vedotin (EV...
Journal Articles
Subject Area:
Oncology
Takamasa Homma, Kuniaki Tanaka, Naoya Takeda, Yu Okada, Shota Torii, Hideki Esaki, Takashi Sakakibara, Norio Takimoto
Journal:
Case Reports in Oncology
Case Rep Oncol (2023) 16 (1): 1217–1222.
Published Online: 25 October 2023
...Takamasa Homma; Kuniaki Tanaka; Naoya Takeda; Yu Okada; Shota Torii; Hideki Esaki; Takashi Sakakibara; Norio Takimoto Enfortumab vedotin is an antibody-drug conjugate against nectin-4 that is recently being used in the management of patients with urothelial carcinoma. The common adverse events...
Journal Articles
Bunpei Isoda, Masanobu Shiga, Shuya Kandori, Yoshiyuki Nagumo, Takayuki Yoshino, Atsushi Ikeda, Takashi Kawahara, Tomokazu Kimura, Hiromitsu Negoro, Akio Hoshi, Bryan J Mathis, Hiroyuki Nishiyama
Journal:
Case Reports in Oncology
Case Rep Oncol (2023) 16 (1): 429–433.
Published Online: 02 June 2023
...Bunpei Isoda; Masanobu Shiga; Shuya Kandori; Yoshiyuki Nagumo; Takayuki Yoshino; Atsushi Ikeda; Takashi Kawahara; Tomokazu Kimura; Hiromitsu Negoro; Akio Hoshi; Bryan J Mathis; Hiroyuki Nishiyama Enfortumab vedotin (EV) is an antibody-drug conjugate and a promising agent for metastatic urothelial...
